| 05/13/2026 3:06 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:03 PM | Core Scientific (1839341) Issuer Ray Jorge L. (2123780) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 3:54 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2026 3:15 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 6:52 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 11:56 AM | Core Scientific (1839341) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/27/2026 4:30 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 7:59 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/22/2026 3:01 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CORZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Core Scientific and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/21/2026 6:36 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/15/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:25 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:26 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:44 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/31/2026 3:59 PM | Core Scientific (1839341) Filer | Form DEFA14A | |
| 03/31/2026 4:01 PM | Core Scientific (1839341) Filer | Form ARS | |
| 03/31/2026 3:55 PM | Core Scientific (1839341) Filer | Form DEF 14A | |
| 03/27/2026 5:45 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4/A | |
| 03/26/2026 4:39 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 7:29 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/20/2026 7:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/19/2026 3:06 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 4:14 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 03/12/2026 11:55 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 03/10/2026 3:08 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:13 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:05 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/02/2026 3:44 PM | Core Scientific (1839341) Filer | Form 10-Q/A | |
| 03/02/2026 3:18 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 02/19/2026 8:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 02/19/2026 10:56 AM | Core Scientific (1839341) Filer | Form 8-K/A | |
| 02/18/2026 4:16 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 10:11 AM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 5:08 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (Ad) Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The Financial Times estimates this move could help unleash $100 trillion in new wealth.
Billionaire investors John Paulson, Ray Dalio, and Paul Tudor Jones are already said to be preparing. The window to get ahead of this may be closing. Click here to see the full details before May 15 |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Levy Jordan (1541436) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Booth Jeffrey David (2009493) Reporting Core Scientific (1839341) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:15 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 8:07 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 01/07/2026 1:59 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/02/2026 5:26 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 7:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 12/10/2025 5:12 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 12/01/2025 7:04 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/17/2025 5:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/13/2025 4:42 PM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2025 3:05 PM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 10/31/2025 4:16 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/31/2025 3:27 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 3:18 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:55 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/30/2025 9:28 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/28/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/24/2025 3:14 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/24/2025 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 4:20 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/22/2025 3:44 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/21/2025 4:22 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 4:00 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/17/2025 5:09 AM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/16/2025 4:22 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/15/2025 3:45 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2025 3:48 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/14/2025 4:50 PM | Core Scientific (1839341) Subject Situational Awareness LP (2045724) Filed by | Form SCHEDULE 13D/A | |
| 10/14/2025 7:30 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/10/2025 7:48 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/10/2025 7:55 PM | Core Scientific (1839341) Subject | Form 425 | |
| 10/10/2025 4:27 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 10/10/2025 4:02 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/09/2025 6:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/07/2025 4:27 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:27 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:23 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 10/07/2025 4:24 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 09/29/2025 9:06 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DFAN14A | |
| 09/29/2025 7:00 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form DEFC14A | |
| 09/26/2025 4:26 PM | Core Scientific (1839341) Filer | Form DEFM14A | |
| 08/14/2025 9:29 AM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G | |
| 08/08/2025 8:40 AM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D | |
| 07/29/2025 10:21 AM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
Your book is inside (Ad) The "Sucker's Bet" Most New Options Traders Fall For
Most people who try options lose money the same way.
They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter.
Normally $29.97. Free today. Download your copy now. |
| 07/16/2025 6:02 PM | BlackRock, Inc. (2012383) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 07/14/2025 4:10 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/14/2025 4:10 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/14/2025 4:12 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/09/2025 4:02 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/08/2025 4:22 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/08/2025 5:09 AM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/07/2025 4:23 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |
| 07/07/2025 4:24 PM | Core Scientific (1839341) Subject CoreWeave, Inc. (1769628) Filed by | Form 425 | |